Valuation : Grand Pharmaceutical Group Limited

Market Cap 17.19B 2.19B 1.89B 1.78B 1.62B 3.03B 207B 3.04B 20.98B 8.14B 106B 8.23B 8.05B 342B P/E 2026 *
9.58x
P/E 2027 * 8.73x
Enterprise Value 17.19B 2.19B 1.89B 1.78B 1.62B 3.03B 207B 3.04B 20.98B 8.14B 106B 8.23B 8.05B 342B EV / Sales 2026 *
1.33x
EV / Sales 2027 * 1.22x
Free-Float
34.99%
Yield 2026 *
4.18%
Yield 2027 * 4.68%
1 day+0.61%
1 week-6.30%
Current month-2.19%
1 month-4.01%
3 months-5.03%
6 months-31.71%
Current year-37.45%
1 week 4.82
Extreme 4.825
5.28
1 month 4.82
Extreme 4.825
5.72
Current year 4.53
Extreme 4.53
8.18
1 year 4.53
Extreme 4.53
9.55
3 years 3.17
Extreme 3.17
10.2
5 years 3.17
Extreme 3.17
10.2
10 years 1.36
Extreme 1.36
10.2
Manager TitleAgeSince
Chief Executive Officer 36 01/06/2021
Corporate Secretary 57 01/09/2011
Director TitleAgeSince
Director/Board Member 63 21/03/2005
Director/Board Member 66 12/05/2011
Director/Board Member 62 31/12/2018
Date Insider Type Main position Quantity % Market Cap. Importance
4/22/26 A Other

Chairman

50,000 0.0014%
4/21/26 A Other

Chief Executive Officer

58,500 0.0016%
3/27/26 A Other

Chairman

60,000 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
+0.61%-6.30%-45.32%+23.06% 2.19B
-0.88%-2.15%+58.05%+105.91% 1,024B
-1.15%+2.68%+54.25%+71.29% 663B
-1.44%+0.38%+20.65%+75.54% 453B
+0.14%-0.47%+30.20%+40.61% 352B
-1.33%+4.72%+24.62%+47.60% 304B
-1.15%+0.30%-0.69%+11.83% 252B
-1.55%+1.11%+54.15%+72.13% 236B
-0.88%+1.15%-14.60%-54.84% 206B
-0.15%+3.65%+31.24%+100.90% 187B
Average -0.78%+0.35%+21.25%+49.40% 368.06B
Weighted average by Cap. -0.96%+0.54%+37.58%+66.98%

Financials

2026 *2027 *
Net sales 12.95B 1.65B 1.42B 1.34B 1.22B 2.28B 156B 2.29B 15.8B 6.13B 79.99B 6.2B 6.07B 258B 14.14B 1.8B 1.55B 1.46B 1.33B 2.5B 170B 2.5B 17.25B 6.7B 87.36B 6.77B 6.62B 281B
Net income 1.82B 232M 200M 188M 172M 321M 21.91B 322M 2.22B 862M 11.24B 871M 852M 36.22B 2B 255M 219M 206M 188M 352M 24.05B 353M 2.44B 946M 12.34B 957M 936M 39.76B
Net Debt - -
Logo Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company is mainly engaged in the manufacture and sale of pharmaceutical preparations and medical devices. The Company is also engaged in the manufacture and sale of biotechnology products, health products, specialised pharmaceutical raw materials and other products. The Company's main products include nuclear medicine anti-tumor diagnosis and treatment and cardiovascular and cerebrovascular interventional diagnosis and treatment technology products.
Employees
12,326
Date Price Change Volume
04/09/26 HK$4.910 +0.61% 3,896,500
03/09/26 HK$4.880 +0.41% 6,613,500
02/09/26 HK$4.860 -3.28% 8,014,500
01/09/26 HK$5.025 +0.10% 5,119,000
31/08/26 HK$5.020 -4.20% 7,087,500
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.910HKD
Average target price
9.527HKD
Spread / Average Target
+94.03%

Annual profits - Rate of surprise